PURA - Puration Pursues M&A Strategy in Cannabis Consolidation Market
January 29 2020 - 12:34PM
InvestorsHub NewsWire
Dallas, TX -- January 29, 2020 --
InvestorsHub NewsWire -- Puration, Inc. (USOTC:
PURA) today announced plans to further pursue the prevailing
cannabis consolidation market opportunity by acquiring smaller
cannabis infusion companies. Multiple cannabis investment
market analysts have forecasted a market wide consolidation as
larger cannabis sector firms acquire smaller firm. PURA has
built expertise and resources to infuse cannabis into beverages and
is now looking to expand the capacity to include food infusion
capacity. PURA is currently exploring the acquisition of
Kali-Extracts’ (USOTC:
KALY) CBD confections business. PURA management now
confirms that the company is also exploring additional acquisition
opportunities. PURA currently produces the leading CBD
beverage in the sports nutrition market, EVERx CBD Sports
Water. EVERx now has distribution in Europe, Latin America
and Africa in addition to within the United States. PURA
management believes the company is well staged for acquiring and
growing additional cannabis infused beverages and
foods.
For more information on Puration,
visit http://www.purationinc.com
Disclaimer/Safe
Harbor:
This news release contains forward-looking
statements within the meaning of the Securities Litigation Reform
Act. The statements reflect the Company's current views with
respect to future events that involve risks and uncertainties.
Among others, these risks include the expectation that any of the
companies mentioned herein will achieve significant sales, the
failure to meet schedule or performance requirements of the
companies' contracts, the companies' liquidity position, the
companies' ability to obtain new contracts, the emergence of
competitors with greater financial resources and the impact of
competitive pricing. In the light of these uncertainties, the
forward-looking events referred to in this release might not occur.
These statements have not been evaluated by the Food and Drug
Administration. These products are not intended to diagnose, treat,
cure, or prevent any disease.
Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800)
861-1350
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Apr 2023 to Apr 2024